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Objectives: To determine trends in the prevalence and aetiological distribution of genital ulcer syndrome
(GUS) in a cohort of female bar workers and to assess factors associated with these trends.
Methods: An open cohort of 600 women at high risk of HIV and sexually transmitted infection (STI) was
offered screening and treatment for STI at 3-month intervals. The prevalence of GUS and associated
aetiological agents (Herpes simplex virus (HSV), Treponema pallidum and Haemophilus ducreyi) were
monitored over 27 months through clinical examination, dry lesion swabbing and multiplex polymerase
chain reaction. The effects of HIV status and other factors on the prevalence trends of STI were assessed.
Results: A total of 753 women were recruited into the cohort over 10 examination rounds. At recruitment, the
seroprevalence was 67% for HIV and 89% for HSV type 2 (HSV-2). During follow-up, 57% of ulcers had
unknown aetiology, 37% were due to genital herpes and 6% to bacterial aetiologies, which disappeared
completely in later rounds. The absolute prevalence of genital herpes remained stable at around 2%. The
proportion of GUS caused by HSV increased from 22% to 58%, whereas bacterial causes declined. These
trends were observed in both HIV-negative and HIV-positive women.
Conclusions: The changes observed in the frequency and proportional distribution of GUS aetiologies suggest
that regular STI screening and treatment over an extended period can effectively reduce bacterial STI and
should therefore be sustained. However, in populations with a high prevalence of HSV-2, there remains a
considerable burden of genital herpes, which soon becomes the predominant cause of GUS. Given the
observed associations between genital herpes and HIV transmission, high priority should be given to the
evaluation of potential interventions to control HSV-2 either through a vaccine or through episodic or
suppressive antiviral therapy and primary prevention.
U
lcerative sexually transmitted infection (STI) is well
recognised as an epidemiological and biological risk factor
for HIV transmission.1 2 In sub-Saharan Africa, the most
frequent causative agents include Herpes simplex virus type 2
(HSV-2), Treponema pallidum and Haemophilus ducreyi, whereas
Chlamydia trachomatis and Chlamydia granulomatis are less frequent
aetiologies. The proportion of genital ulcers caused by HSV-2 is
increasing among patients with ulcers presenting at clinics in
countries with severe HIV epidemics,3–7 and this could be partly due
to an absolute increase in symptomatic genital herpes cases in HIV/
HSV-2 coinfected individuals, thus increasing the transmission of
HSV-2.7 8 However, epidemic simulation modelling has shown that
this phenomenon alone is unlikely to result in the pronounced
shifts in ulcer aetiologies observed in some settings, unless it
coincides with decreases in the incidence of syphilis and chancroid
owing to behaviour change and/or improved STI management.9
To shed light on the complex inter-relationships between
ulcerative STI, HSV-2 and HIV in the presence of behavioural and
clinical HIV/STI control interventions, a prospective study was
carried out among a cohort of female bar workers in Mbeya
Region, Tanzania. The objectives of the study were to determine
the trends in the prevalence and aetiological distribution of
genital ulcer syndrome (GUS) and to assess to what extent these
trends were related to HIV status and sexual risk behaviours.
METHODS
The study protocol was approved by the ethics committees of
the Tanzanian National Institute for Medical Research, Dar es
Salaam, Tanzania, and the London School of Hygiene &
Tropical Medicine, London, UK.
In 2000, an open cohort of 600 female bar workers was
established in Mbeya Region, Tanzania. Participants were
recruited among women working in bars, restaurants and
guesthouses at 14 communities along highways in Mbeya
Region, and followed up at 3-month intervals for up to
27 months. An additional 153 women were recruited to replace
women lost to follow-up during the study. At each 3-month
visit, participants were offered STI screening and on-the-spot
syndromic STI treatment, health education, HIV voluntary
testing and counselling, and condoms. Information on beha-
viours was collected through structured interviews. Participants
underwent genital examinations and were serologically
screened for syphilis, HIV and HSV-2 infection. Treatment for
STI did not include antiviral drugs for HSV. HIV antiretroviral
therapy has been introduced to the region recently, but was not
yet available to people infected with HIV at the time of this
study. Further details of the bar worker cohort and the HIV/STI
prevention and care services provided have been reported
elsewhere.10
Disruptions of the genital epithelium were diagnosed as
ulcers and vesicular lesions as blisters. The term GUS (used
synonymously with genital lesions) was used to denote genital
ulcers and/or blisters. A multiplex polymerase chain reaction
Abbreviations: GUS, genital ulcer syndrome; HSV, herpes simplex virus;
HSV-2, herpes simplex virus type 2; PCR, polymerase chain reaction; STI,
sexually transmitted infection.
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(M-PCR was used for the detection of T pallidum, H ducreyi and
HSV from a single dry ulcer swab in the Department of
Microbiology, University of Manitoba, Winnipeg, Manitoba,
Canada.11 The HIV serostatus was determined through a dual-
testing strategy (HIV-Determine, Abbott, Abbott Laboratories,
Abbott Park, Illinois, USA, and Enzygnost HIV1+2 plus,
Behring, Germany), and discrepant results were resolved by
western blot (HIV Blot 2.2, Genelabs Diagnostics, Singapore,
Singapore). HSV-2 IgG were detected with an enzyme immune
assay (KALON Biological, Aldershot, UK).
Data from all 10 examination rounds were combined to
assess the association between HIV status and GUS. A random
effects logistic regression model was used to take account of
repeated measurements on individual participants, and the
model adjusted for other potential confounding factors includ-
ing HSV-2 status. Odds ratios (ORs) for trend were used to
evaluate trends in the prevalence of GUS across the 10 rounds
of follow-up, but the proportional distribution of GUS aetiologies
was assessed by grouping rounds 1–3, 4–6 and 7–10. The effect of
different sexual behaviours on these trends was assessed by
comparing crude ORs with adjusted ORs in turn for each of these
factors. A subanalysis was performed on those women who
seroconverted for HIV, to compare the odds of GUS occurring in
the round before, at or after the first HIV-positive result,
controlling for the study round.
RESULTS
Prevalence of HIV, HSV-2 and GUS
The prevalence of HIV, HSV-2 and HIV/HSV-2 coinfection
among all 753 women at recruitment was 66.9%, 88.8% and
63.7%, respectively. At a total of 5762 examinations, GUS was
diagnosed 312 times in 227 individual women (table 1). A
single episode of GUS was recorded in 161 women, whereas 2–5
episodes were recorded in a further 66 women. Genital herpes
was diagnosed at 116 examinations (2%), syphilitic lesions at
12 (0.2%) and chancroid at 7 (0.1%). No aetiological agent was
found in 178 GUS cases (3.1%; table 1).
GUS aetiologies
A large proportion of GUS (178/312; 57%), including 31% of
blisters and 64% of ulcers, was not attributable to detectable
pathogens. HSV alone was detected in 115 (37%) lesions, T
pallidum alone in 11 (4%) lesions and H ducreyi in 7 (3%)
lesions. In addition, there was one mixed infection with HSV
and T pallidum (0.3%). All the 17 lesions consisting of both
ulcers and blisters were caused by HSV. Only 132 of 312 (42%)
women were aware of their lesions. Awareness was greatest
among women with genital herpes (51%) and lower in women
with primary syphilis (5/11), chancroid (3/7) and lesions
without aetiology (37%); however, these differences were not
significant (p = 0.16).
Although 26% of all lesions and 50% of lesions without
detectable aetiology were believed by clinicians to be of non-
infectious (traumatic through scratching or shaving) origin, on
the basis of the physical appearance, this was the case for none
of the syphilitic and chancroidal lesions and for only 5% of
herpetic lesions; 91% (41/45) of these lesions were pathogen
negative.
Association of follow-up status and GUS
During the observation period, 153 women were lost to follow-
up; 55 of these women died, of whom 54 were infected with
HIV. The observed prevalence of GUS was highest among
women who later died (13.9%), followed by women who
dropped out for other or unknown reasons (8.8%) and lowest
among women who completed follow-up (4.7%). These
differences were statistically significant (p = 0.001 and
p = 0.03, respectively). Women who died later were more likely
to have herpetic lesions than women who completed follow-up
(adjusted OR 4.22, 95% confidence interval (CI) 2.25 to 7.92).
This association remained when the analysis was restricted to
HIV-positive women (adjusted OR 3.05, 95% CI 1.62 to 5.71).
Association of HIV status and GUS
Excluding the round of HIV seroconversion to exclude GUS due
to acute seroconversion illness, GUS was diagnosed at 277
(6.9%) of 4007 examinations of HIV-positive women, compared
with 32 (1.9%) of 1714 examinations of HIV-negative women
(OR 4.02, 95% CI 2.71 to 5.95; table 2). Except for syphilitic
ulcers, both pathogen-positive and pathogen-negative lesions
were more prevalent among HIV-positive women with crude
ORs in the range 3.5–6.2. Chancroid was seen only in HIV-
infected women. Including the round of HIV seroconversion
had a modest effect on the strength of the association between
GUS and HIV infection (table 2).
The association between HIV and GUS was stronger in HSV-2
seropositive women (OR 4.02, 95% CI 2.61 to 6.19) than in
HSV-2 seronegative women (OR 2.55, 95% CI 0.68 to 10.97);
however, this difference was not significant (test for interac-
tion: p = 0.44). The association between HIV and GUS was still
highly significant after adjusting for HSV-2 status (table 2), and
was not due to confounding by differences in reported sexual
behaviour between HIV-positive and HIV-negative women.
Frequency of GUS in relation to HIV seroconversion
The prevalence of GUS at the approximate time of HIV
seroconversion (8.3%; 3/36 examinations) was higher than at
visits after seroconversion (5.3%; 11/208 examinations) or
before seroconversion (2.0%; 2/99 examinations). Compared
with the risk of GUS before HIV seroconversion and after
adjusting for the examination round, ORs for GUS risk were
4.94 (95% CI 0.78 to 31.22; p = 0.09) at the approximate time of
seroconversion and 5.72 (95% CI 1.05 to 31.11; p = 0.06) at
visits after seroconversion. However, the number of HIV
seroconversions was small, and overall these differences were
not significant (p = 0.1).
Prevalence trends of GUS over 10 examination rounds
The prevalence of GUS decreased from 10.2% at the first
examination round to 1.2% at the tenth round (ORtrend 0.85,
95% CI 0.82 to 0.89; table 3). Pathogen-negative GUS decreased
markedly (ORtrend 0.78, 95% CI 0.73 to 0.83), partly due to a
decrease in ulcers of presumed traumatic origin (ORtrend 0.69,
95% CI 0.58 to 0.82). The prevalence of genital herpes
fluctuated around 2% (ORtrend 1, 95% CI 0.93 to 1.07), whereas
Table 1 Prevalence of genital ulcer syndrome in a cohort
of female bar workers in Mbeya, Tanzania
Clinical diagnoses and
aetiological agents
Proportion of cases/5762
examinations (%)
Clinical diagnosis
GUS (ulcer and/or blister) 312* (5.4)
Genital ulcer 277* (4.8)
Genital blister 52* (0.9)
Mixed lesions: genital ulcer and blister 17 (0.3)
Aetiological agents
HSV (genital herpes) 116 (2.0)
T pallidum (primary syphilis) 12 (0.2)
H ducreyi (chancroid) 7 (0.1)
Ulcer without detectable aetiology 178 (3.1)
GUS, genital ulcer syndrome; HSV, Herpes simplex virus.
*Including 17 GUS of mixed type (both ulcer and blister).
Including 1 GUS with mixed aetiology (T pallidum and HSV).
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primary syphilis and chancroid were not seen at all at later
examination rounds with OR for trend of 0.76 (95% CI 0.61 to
0.96) and 0.76 (95% CI 0.56 to 1.03), respectively. The trend in
the prevalence of genital herpes was assessed separately in HIV-
positive women, because herpetic lesions could have increased
over time as immune deficiency progressed; no increase was
observed (ORtrend 0.99, 95% CI 0.93 to 1.06).
To assess the possibility that the observed decrease in GUS
could have been due to the selective loss to follow-up of women
with a relatively high prevalence of ulcers, trends in the
prevalence of GUS and genital herpes were analysed separately
in women who completed follow-up. A non-significant increase
was observed in GUS in women later lost to follow-up (ORtrend
1.07, 95% CI 0.95 to 1.2), and their exclusion had only a
minimal effect on the rate of decline (ORtrend 0.84, 95% CI 0.81
to 0.89). Genital herpes increased significantly in women later
lost to follow-up (ORtrend 1.36, 95% CI 1.00 to 1.85), whereas
there was no significant increase in women completing follow-
up (ORtrend 1.01, 95% CI 0.93 to 1.08).
The observed time trends in GUS were not explained by
reported changes in sexual behaviour (data not shown).
Changes in aetiological patterns of ulcerative STI over
time
Table 4 shows changes in the proportional distribution of ulcer
aetiologies over time. The proportion of GUS caused by HSV
increased from 22.5% at examination rounds 1–3 to 58.4% at
rounds 7–10 (ORtrend 2.58, 95% CI 1.71 to 3.89), whereas that of
lesions without detectable aetiology decreased from 69.6% to
39% (ORtrend 0.46, 95% CI 0.32 to 0.68). These changes were
independent of HIV status (tests for interaction of HIV status
with trends in the proportional distribution of all three
pathogens and pathogen-negative lesions; p>0.30. The data
were reanalysed excluding pathogen-negative lesions. HSV was
predominant from the start, causing an average of 73.8%
pathogen-positive lesions during rounds 1–3 and increasing to
95.7% during rounds 7–10. The proportion of GUS caused by T
pallidum and H ducreyi dropped from 14.3% and 11.9%,
Table 2 Association of HIV status and genital ulcer syndrome
STI
HIV2ve,
n = 1714*
HIV+ve,
n = 4007*
All,
n = 5721*
OR` (95% CI)
Adjusted OR
(95% CI)`1 p Value`1 OR`n (%) n (%) n (%)
GUS 32 (1.9) 277 (6.9) 309 (5.4) 4.02 (2.71 to 5.95) 3.8 (2.55 to 5.68) ,0.001 3.91 (2.20 to
6.98)
HSV-2 seropositive 1.9% 7% 5.7% 4.02 (2.61 to 6.19)
HSV-2 seronegative 1.8% 4.1% 2.5% 2.55 (0.68 to 9.54)
Pathogen +ve lesion 13 (0.8) 120 (3) 133 (2.3) 4.14 (2.28 to 7.51) 3. 91 (2.13 to 7.19) ,0.001 3.91 (2.20 to
6.98)
HSV-2 seropositive 0.7% 3.1% 2.4% 4.42 (2.26 to 8.65)
HSV-2 seronegative 0.9% 1.4% 1% 1.52 (0.25 to 9.17)
Pathogen 2ve lesion 19 (1.1) 157 (3.9) 176 (3.1) 3.7 (2.25 to 6.1) 3.51 (2.11 to 5.85) ,0.001 3.38 (2.10 to
5.46)
HSV-2 seropositive 1.2% 4% 3.2% 3.55 (2.07 to 6.09)
HSV-2 seronegative 0.9% 2.7% 1.5% 3.22 (0.66 to 15.8)
Genital herpes 8 (0.5) 108 (2.7) 116 (2) 6.23 (2.94 to 13.21) NA 0.001 6.38 (3.01 to
13.50)
Primary syphilis 5 (0.3) 6 (0.2) 11 (0.2) 0.51 (0.16 to 1.68) 0.27 0.43 (0.14 to 1.35)
Chancroid 0 (0) 7 (0.2) 7 (0.1) 0.11**
GUS, genital ulcer syndrome; HSV-2, Herpes simplex virus type 2; STI, sexually transmitted infection; NA, not applicable; +ve, positive; 2ve, negative.
*Excluding five examinations in one participant with indeterminate HIV status.
All examinations, excluding HIV seroconverters at time of seroconversion.
`Random effects logistic regression with individual participants as group variable.
1Adjusted for HSV-2 status.
All examinations, including HIV seroconverters at time of seroconversion.
**Fisher’s exact test. Numbers too small to compute OR.
Table 3 Prevalence of clinical signs and aetiological agents of genital ulcer syndrome over 10 examination rounds
STI
Round 1
n = 600
Round 2
n = 570
Round 3
n = 573
Round 4
n = 570
Round 5
n = 562
Round 6
n = 565
Round 7
n = 593
Round 8
n = 584
Round 9
n = 567
Round 10
n = 578
ORtrend*
(95% CI) p Value Trend
GUS 61 (10.2) 37 (6.5) 40 (7) 37 (6.5) 28 (5) 32 (5.7) 33 (5.6) 18 (3.1) 19 (3.4) 7 (1.2) 0.85 (0.82
to 0.89)
,0.001 Q
T pallidum 5 (0.8) 0 (0) 1 (0.2) 2 (0.3) 1 (0.2) 1 (0.2) 1 (0.2) 1 (0.2) 0 (0) 0 (0) 0.76 (0.61
to 0.96)
0.02 Q
H ducreyi 0 (0) 2 (0.4) 3 (0.5) 0 (0) 1 (0.2) 1 (0.2) 0 (0) 0 (0) 0 (0) 0 (0) 0.76 (0.55
to 1.03)
0.08 Q
HSV 10 (1.7) 15 (2.6) 6 (1) 10 (1.7) 10 (1.8) 20 (3.5) 18 (3) 9 (1.5) 12(2.1) 6 (1) 1 (0.93
to 1.07)
0.99 «
Any of the
above
pathogens
15 (2.5) 17 (3) 10 (1.8) 12 (2.1) 12 (2.1) 21 (3.7) 19 (3.2) 10 (1.7) 12 (2.1) 6 (1) 0.96 (0.91
to 1.02)
0.23 «
Pathogen
negative
46 (7.7) 20 (3.5) 30 (5.2) 25 (4.4) 16 (2.9) 11 (2) 14 (2.4) 8 (1.4) 7 (1.2) 1 (0.2) 0.78 (0.73
to 0.83)
,0.001 Q
Values are n(%) unless indicated otherwise.
GUS, genital ulcer syndrome; HSV, Herpes simplex virus; STI, sexually transmitted infection.
*OR for linear trend from one study round to the next, estimated using random effects logistic regression to allow for correlations between repeated measurements on
individual women.
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respectively, during the first period to 4.3% and 0% during the
last period.
DISCUSSION
GUS aetiologies
The seroprevalences of HSV-2 (89%), HIV (67%) and HSV-2/
HIV coinfection (64%) were high among cohort participants. It
is therefore not surprising that HSV was a frequent aetiology of
GUS. As molecular typing of HSV was not done, it is possible
that some herpetic lesions were caused by HSV type 1.
However, a recent study using molecular typing on ulcer
specimens from GUS patients in Dar es Salaam, Tanzania, did
not find HSV type 1 in a single case.12
T pallidum was detected in only 12 (4%) and H ducreyi in 7
(2%) specimens collected from women with GUS. These
proportions are low compared with findings of other studies
carried out among patients with GUS in sub-Saharan
Africa,4 11 13 14 but confirm results of a recent study among
patients with GUS in Mbeya, where T pallidum was not found in
any of 34 female patients and H ducreyi was only found in one
single case (3%).15 It is possible that owing to a long standing
STI intervention programme in Mbeya Region (in place since
1990), bacterial ulcerative STIs have already been effectively
reduced, and this is supported by the steep decline in syphilis
observed during the 1990s in antenatal care attendees.16
The proportion of M-PCR negative results (57%) was
unexpectedly high and decreased over time. In other studies
using M-PCR, the proportion of pathogen-negative specimens
ranges from 22%5 to 51%,17 and tends to be larger in population-
based studies where genital ulcers are detected through
screening of ‘‘healthy’’ individuals than in clinic-based studies
of patients self-presenting with genital ulcers. Specimen taking
was standardised as much as possible—for example, through
clear case definitions of GUS and standardised sample
collection procedures. However, if in doubt, study clinicians
were likely to diagnose GUS and take a swab rather than risk
missing a true STI case. Especially during the initial phase of
the study, when the clinical team was inexperienced, this has
certainly resulted to some extent in misclassification of other
skin lesions as GUS. Furthermore, study clinicians suggested,
on the basis of the physical appearance of ulcers, that a large
proportion (26%) of lesions may have been provoked by women
themselves through small traumata caused by shaving or
scratching. As 91% (41/45) of these lesions were pathogen
negative, this inference was often correct. Moreover, in some
cases, pathogens may have been eradicated through antibiotic
treatment before specimen taking and, lastly, the presence of
additional aetiological agents, which cannot be detected by
M-PCR, must be considered.
Effect of HIV infection on the prevalence of GUS
GUS and genital herpes specifically, were more prevalent
among HIV-infected women. The association between genital
herpes and positive HIV serostatus was strong as observed in
many other cross-sectional and prospective studies.1 However,
reports on pathogen-negative ulcers associated with HIV
infection are rare,18 19 and we have no plausible explanation
for this observation.
The prevalence of HSV-2 was higher among HIV-positive
than among HIV-negative women, which could have been a
simple explanation for the higher frequency of GUS among
HIV-infected women. However, the higher prevalence of GUS
in HIV-infected women was to a large extent independent of
the HSV-2 status. This is consistent with HIV/HSV-2 coinfected
women being at higher risk of developing herpetic lesions.
Symptomatic herpes occurred especially frequently among
women who died later probably of HIV-related causes,
suggesting that advanced immune deficiency was associated
with increased frequency of herpetic episodes. GUS with no
detectable pathogen also occurred more frequently among
women compared with women lost to follow-up for other or
unknown reasons. This suggests that HIV and/or advanced
immune deficiency may have caused or exacerbated lesions of
unknown origin.
GUS occurred more frequently around the time of HIV
seroconversion. Data do not allow us to determine whether
genital lesions were present during the weeks before, at the
same time as or during the weeks immediately after women
acquired HIV. Nonetheless, the observations in Mbeya are
consistent with the hypotheses that genital lesions may
Table 4 Changes in the proportional distribution of genital ulcer syndrome aetiologies over
time
STI
Period* 1
(rounds 1–3)
Period* 2
(rounds 4–6)
Period* 3
(rounds 7–10) ORtrend
(95% CI) p Value Trendn (%) n (%) n (%)
All GUS (total n) 138 97` 77
HSV (PCR) 31 (22.5) 40 (41.2) 45 (58.4) 2.58 (1.71
to 3.89)
,0.001 q
T pallidum (PCR) 6 (4.4) 4 (4.1) 2 (2.6) 0.9 (0.11
to 7.65)
0.93 «
H ducreyi (PCR) 5 (3.6) 2 (2.1) 0 (0) 0.34 (0.09
to1.3)
0.12 Q
Pathogen-negative 96 (69.6) 52 (53.6) 30 (39) 0.46 (0.32
to 0.68)
,0.001 Q
All pathogen-positive GUS
(total n)
42 45` 47
HSV (PCR) 31 (73.8) 40 (88.9) 45 (95.7) 7.27 (0.40
to 131.15)
0.18 q
T pallidum (PCR) 6 (14.3) 4 (8.9) 2 (4.3) 0.18 (0
to 6.23)
0.34 Q
H ducreyi (PCR) 5 (11.9) 2 (4.4) 0 (0) 0.22 (0.05
to 0.87)
0.03 Q
GUS, genital ulcer syndrome; HSV, Herpes simplex virus; PCR, polymerase chain reaction; STI, sexually transmitted
infection.
*One round is equivalent to a time period of 3 months, during which all participants were examined once.
OR for linear trend with one unit increase in period using random effects logistic regression to allow for correlations
between repeated measurements on individual women—see table 3 footnotes.
`Including one lesion with mixed aetiology (HSV and T pallidum).
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increase susceptibility to HIV, that genital ulcers are a sign of
acute HIV seroconversion illness and/or that HIV is frequently
acquired from dually infected male partners (with HIV and
ulcerative STI).
Decline in GUS over time
The prevalence of GUS among cohort participants declined
gradually with successive examination rounds, and this was
mainly due to a decrease in pathogen-negative lesions. The
prevalence of syphilis and chancroid also declined, but case
numbers were too small to contribute substantially to the
overall decline in GUS. The decline in bacterial infections was
probably real, as it coincided with declines in other treatable
STIs such as gonorrhoea, chlamydia and trichomoniasis.10 20 The
reduction in these STIs may be attributable to regular STI
screening and treatment and education on HIV/STI prevention
provided to cohort participants. A true reduction in lesions of
non-infectious origin also seems possible, as women may
increasingly have taken precautions to avoid traumata through
scratching or shaving following advice from clinicians and
nurses. In addition, however, the specificity of the diagnosis of
GUS may have increased over time as clinicians became more
experienced, resulting in declining proportions of participants
diagnosed with GUS. Conversely, it cannot be excluded that
some true cases of ulcerative STI were missed during later study
rounds. It is reassuring that clinicians correctly attributed all
syphilis and chancroid cases and the great majority of herpes
cases to an infectious origin as opposed to a mechanical origin,
on the basis of clinical signs.
The risk of GUS, including that of genital herpes, chancroid
and pathogen-negative lesions, was 2–5 times higher in women
lost to follow-up than in those who remained in the study. The
selective loss to follow-up of women at high risk of GUS may have
contributed to the decline in prevalence of ulcers. If this were the
case, the decline in GUS should have been less pronounced or
non-existent if women lost to follow-up were excluded from data
analysis. Such a difference was not observed with regard to GUS.
However, the loss of women with frequent herpes episodes may
have masked a genuine increase in the prevalence of genital
herpes in the cohort over time.
Changes in the proportional distribution of ulcer
aetiologies over time
The number of syphilis, chancroid and pathogen-negative cases
decreased over time, whereas the number of genital herpes cases
fluctuated around an average of 12 cases per examination round.
This resulted in an increase in the proportion of GUS caused by
HSV (although absolute numbers of genital herpes cases did not
increase), and a proportional decrease in those caused by T
pallidum, H ducreyi and of pathogen-negative cases. This is likely to
reflect a scenario where bacterial STI are successfully controlled,
although genital herpes remains uncontrolled and therefore
becomes more predominant.21 The fact that the proportional
increase in HSV as an aetiological agent occurred in HIV-infected
and in HIV-uninfected women suggests that a potential increase
in the incidence of herpetic episodes associated with progression
of immune deficiency in HIV-infected women played only a
limited role in these changes.
CONCLUSIONS
The changes observed in the frequency and proportional
distribution of GUS aetiologies suggest that regular STI
screening and treatment over an extended period can effec-
tively reduce bacterial STI and should therefore be sustained.
However, in populations with a high prevalence of HSV-2, there
remains a considerable burden of genital herpes, which soon
becomes the predominant cause of GUS. Given the observed
associations between genital herpes and HIV transmission, high
priority should be given to the evaluation of potential
interventions to control HSV-2 either through a vaccine or
through episodic or suppressive antiviral therapy.
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